Home/Hillstar Bio/Jianwen Feng

JF

Jianwen Feng

Sr Director, Antibody Research

Therapeutic Areas

Autoimmune Diseases Immunology

Hillstar Bio Pipeline

Drug	Indication	Phase
HSB-101	Axial Spondyloarthritis (AxSpA) & other HLA-B27-mediated conditions	Preclinical
Undisclosed Immune Cell Depleter	Undisclosed	Lead Optimization

Leadership Team at Hillstar Bio

Vice President of Program Management

Douangsone Vadysirisack

Vice President of Immunology

Executive Chair of the Board

View full Hillstar Bio profile